The impact of chemokine receptor CXCR4 on breast cancer prognosis: A meta-analysis

Cancer Epidemiology

Volumn 37, Issue 5, 2013, Pages 725-731

  Xu, Tong peng ^a   Shen, Hua ^a   Liu, Ling xiang ^a   Shu, Yong qian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; C X C chemokine receptor type 4 (CXCR4); Meta analysis; Prognosis

Indexed keywords

CHEMOKINE RECEPTOR CXCR4;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER THERAPY; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL DECISION MAKING; CYTOPLASM; DISEASE FREE SURVIVAL; EMBASE; HUMAN; MEDLINE; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBLISHING; QUALITY CONTROL; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; WHOLE CELL;

BREAST CANCER; C-X-C CHEMOKINE RECEPTOR TYPE 4 (CXCR4); META-ANALYSIS; PROGNOSIS;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CXCR4; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84884125127     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.04.017     Document Type: Article

References (30)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics 2005. CA Cancer J Clin 2005, 55:10-30.
2. Schier A.F. Chemokine signaling: rules of attraction. Curr Biol 2003, 13:R192-R194.
3. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 1994, 55:97-179.
4. Yoshie O., Imai T., Nomiyama H. Chemokines in immunity. Adv Immunol 2001, 78:57-110.
5. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872-877.
6. Schimanski C.C., Schwald S., Simiantonaki N., Jayasinghe C., Gönner U., Wilsberg V., et al. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res 2005, 11:1743-1750.
7. Schimanski C.C., Bahre R., Gockel I., Müller A., Frerichs K., Hörner V., et al. Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer 2006, 95:210-217.
8. Wang L., Wang L., Yang B., Yang Q., Qiao S., Wang Y., et al. Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis. Clin Exp Metastasis 2009, 26:1049-1054.
9. Jiang Y.P., Wu X.H., Shi B., Wu W.X., Yin G.R. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol 2006, 103:226-233.
10. Kang H., Watkins G., Douglas-Jones A., Mansel R.E., Jiang W.G. The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer. Breast 2005, 14:360-367.
11. Yasuoka H., Tsujimoto M., Yoshidome K., Nakahara M., Kodama R., Sanke T., et al. Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis. BMC Cancer 2008, 8:340.
12. Hiller D.J., Meschonat C., Kim R., Li B.D., Chu Q.D. Chemokine receptor CXCR4 level in primary tumors independently predicts outcome for patients with locally advanced breast cancer. Surgery 2011, 150:459-465.
13. Chu Q.D., Holm N.T., Madumere P., Johnson L.W., Abreo F., Li B.D. Chemokine receptor CXCR4 overexpression predicts recurrence for hormone receptor-positive, node-negative breast cancer patients. Surgery 2011, 149:193-199.
14. Liu Y., Ji R., Li J., Gu Q., Zhao X., Sun T., et al. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis. J Exp Clin Cancer Res 2010, 29:16.
15. Chu Q.D., Panu L., Holm N.T., Li B.D., Johnson L.W., Zhang S. High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome. J Surg Res 2010, 159:689-695.
16. Holm N.T., Abreo F., Johnson L.W., Li B.D., Chu Q.D. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC). Breast Cancer Res Treat 2009, 113:293-299.
17. Parker C.C., Kim R.H., Li B.D., Chu Q.D. The chemokine receptor CXCR4 as a novel independent prognostic marker for node-positive breast cancer patients. J Surg Oncol 2012, 106:393-398.
18. Salvucci O., Bouchard A., Baccarelli A., Deschênes J., Sauter G., Simon R., et al. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res Treat 2006, 97:275-283.
19. Andre F., Cabioglu N., Assi H., Sabourin J.C., Delaloge S., Sahin A. Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer. Ann Oncol 2006, 17:945-951.
20. Blot E., Laberge-Le Couteulx S., Jamali H., Cornic M., Guillemet C., Duval C., et al. CXCR4 membrane expression in node-negative breast cancer. Breast J 2008, 14:268-274.
21. Mirisola V., Zuccarino A., Bachmeier B.E., Sormani M.P., Falter J., Nerlich A., et al. CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival. Eur J Cancer 2009, 45:2579-2587.
22. Mizell J., Smith M., Li B.D., Ampil F., Chu Q.D. Overexpression of CXCR4 in primary tumor of patients with HER-2 negative breast cancer was predictive of a poor disease-free survival: a validation study. Ann Surg Oncol 2009, 16:2711-2716.
23. Hassan S., Ferrario C., Saragovi U., Quenneville L., Gaboury L., Baccarelli A., et al. The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer. Am J Pathol 2009, 175:66-73.
24. Holm N.T., Byrnes K., Li B.D., Turnage R.H., Abreo F., Mathis J.M., et al. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence. J Surg Res 2007, 141:53-59.
25. Andre F., Xia W., Conforti R., Wei Y., Boulet T., Tomasic G., et al. CXCR4 expression in early breast cancer and risk of distant recurrence. Oncologist 2009, 14:1182-1188.
26. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
27. Tierney J.F., Stewart L.A., Ghersi D., Burdett S., Sydes M.R. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007, 8:16.
28. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses. Eur J Epidemiol 2010, 25:603-605.
29. Müller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
30. Woo S.U., Bae J.W., Kim C.H., Lee J.B., Koo B.W. A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer. Ann Surg Oncol 2007, 15:281-285.